Authored By: Sarah
11 Jul 2024

 Bio-Detection Market Size to grow by USD 16848.8 million between 2024-2028

According to a research report “ Bio-Detection Market” by Application (Clinical, Food and environmental, Defense) Product (Instruments, Accessories and consumables, Reagents and media) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 16848.8 million, at a CAGR of  15.2% during the forecast period. The rise in the prevalence of infectious diseases, including HIV, tuberculosis, pneumonia, and malaria, necessitates a heightened focus on preventive healthcare and early diagnosis. HIV, for instance, attacks the immune system, leading to Acquired Immunodeficiency Syndrome (AIDS) and making individuals more susceptible to secondary infections such as tuberculosis and pneumonia. To address this, various organizations, such as the Aid for AIDS program, provide essential treatments and tools to patients, enabling them to manage their conditions effectively and improve their overall health. This proactive approach to healthcare is crucial for mitigating the impact of compromised immune systems and reducing the spread of these diseases.

Browse market data tables, figures, and in-depth TOC on “Bio-Detection Market” by Application (Clinical, Food and environmental, Defense) Product (Instruments, Accessories and consumables, Reagents and media) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Application, the Clinical segment is projected to dominate the market size in 2024

The global bio-detection market encompasses a range of instruments essential for the diagnosis of infectious diseases. Notably, this segment includes advanced systems such as polymerase chain reaction (PCR) systems, gel electrophoresis systems, and culture test instruments. For instance, Abbott's m2000 RealTime System offers high flexibility and reliability, providing PCR testing for numerous infectious diseases on a single platform. Similarly, Bio-Rad Laboratories' CFX Connect Real-Time PCR Detection System boasts innovative optical technologies and excellent thermal cycler specifications, enabling two-target analysis for diverse laboratory requirements, including infectious disease diagnosis. These instruments play a pivotal role in diagnostic laboratories, ensuring accurate determination of infectious disease concentrations through rigorous validation processes.

By Product, Instruments  segment is expected to hold the largest market size for the year 2024

The clinical segment dominated the global bio-detection market in 2023, driven by the surging demand from critically ill patients post-pandemic and the escalating geriatric population worldwide. Furthermore, the rising incidence of infectious diseases such as influenza and measles in developed and developing countries is fueling the need for bio-detection in clinics. However, the growing preference for POCT (point-of-care testing) bio-detection processes may hinder the segment's expansion during the forecast period.

North America is forecasted to hold the largest market size by region in 2024

The Bio-Detection market represents a significant business opportunity for companies specializing in life sciences and diagnostics. This sector is witnessing robust growth due to increasing demand for early disease detection and rapid diagnostic solutions. Key trends include automation, miniaturization, and integration of artificial intelligence and machine learning algorithms for enhanced accuracy and efficiency. Market size is projected to reach USDXXX billion by 2025, driven by technological advancements and rising healthcare expenditures.

The Bio-Detection Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • 20/20 GeneSystems Inc.
  • 3M Co.
  • Abbott Laboratories
  • AdVnt Biotechnologies LLC
  • Agilent Technologies Inc.
  • Alexeter Technologies LLC
  • Bertin Technologies SAS
  • Bio Rad Laboratories Inc.
  • Bruker Corp.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • MBio Diagnostics Inc.
  • Physical Sciences Inc.
  • PositiveID Corp.
  • Research International Inc.
  • Response Biomedical Corp.
  • Sense Biodetection Inc
  • Smiths Group Plc
  • Thermo Fisher Scientific Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Bio-Detection Market has witnessed significant growth in recent years due to the increasing threat of bio-attacks and the need for early warning systems. With the rising budgets for bio-surveillance, healthcare systems are investing heavily in bio-detection technologies to combat potential health crises. These technologies are essential in identifying and responding to various bio-hazards, including viruses, pathogens, airborne chemicals, and biological weapons. The market has seen a surge in demand following high-profile incidents such as the Ebola outbreaks, H1N1 attack, and Ricin letters. Bio-detection systems play a crucial role in biodefense systems, ensuring clinical urgency in identifying and containing potential threats. The market caters to various applications, including the detection of viruses, potential pathogens, and environmental degradation. Government support has been instrumental in driving the market's growth, with significant investments in research and development. The market also caters to various industries, including healthcare, biotechnology, and homeland security. The potential applications of bio-detection systems extend beyond health crises, with implications for chronic diseases such as kidney disease, cancer, and arsenicosis. Public awareness campaigns are also driving demand for these systems, as individuals and organizations seek to protect themselves from airborne diseases and other bio-hazards.

Market Research Overview

The Bio-Detection Market encompasses a wide range of instruments and technologies used in clinical settings, defense, food and environment sectors for the identification and analysis of various biohazards, including viruses, pathogens, airborne chemicals, and contaminants. Bio-detection technologies include molecular diagnostic techniques such as DNA-based assays, gene sequencing processes, and biosensor-based systems. Clinical applications of bio-detection technologies extend to medical diagnostics, drug toxicology research, and biomarker identification. In the defense sector, these technologies play a crucial role in biodefense against biological warfare agents and potential pathogens. Government support and regulatory policies ensure safety standards and calibration standards are met. Bio-detection instruments include PCD-based assays, gas analyzers, and pathogen testing equipment. Rapid diagnostic kits, biodetection equipment, and next-generation sequencing devices are essential accessories and consumables. Mixtures and compound classes of contaminants, such as xenobiotic metabolism, reproductive toxicity, obesity, genotoxicity, acute stress, and selectivity, can be detected using these technologies. Bio-detection systems are used for various applications, including infection transmission, biodefense systems, and biothreat response. Low-level detection capability and faster reaction times are critical for addressing potential bio-attacks, including viruses, bacteria, and hazardous biological weapons. Bio-surveillance budgets and healthcare systems invest heavily in these technologies to mitigate the risks of bio-terrorism, bioterrorism threat levels, and illnesses or deaths caused by bio-attacks. Bio-detection technologies have a strong presence in the medical field, with applications in chronic diseases such as chronic kidney disease, cancer, and arsenicosis. Public awareness campaigns and environmental degradation also contribute to the growing demand for these technologies. Electrochemiluminescence-based biodetectors, microfluidics-based biodetectors, and microarrays are some of the advanced technologies used for harmful organism biorecognition and antibody detection. Bio-detection technologies are also used for the detection of hazardous chemicals, such as poisons and illicit drugs, and for the analysis of air pollution.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio